- $0.00m
- -$140.92m
- $133.95m
- 67
- 99
- 60
- 88
Annual income statement for Exzeo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 45.6 | 88.3 | 134 |
| Cost of Revenue | |||
| Gross Profit | -26.1 | 17.3 | 53.2 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Total Operating Expenses | 83.4 | 85.8 | 95.9 |
| Operating Profit | -37.8 | 2.55 | 38 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -38.6 | 0.883 | 35.2 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -42 | 12.9 | 26.1 |
| Net Income Before Extraordinary Items | |||
| Extraordinary Items | |||
| Net Income | -59.3 | 21.5 | 45.3 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -68.4 | 12.1 | 35.2 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.564 | 0.039 | 0.176 |